Briggs Morrisons

Syndax Pharmaceuticals Inc (NASDAQ: SNDX) is a clinical stage bio-pharmaceutical company that focuses on development of therapies in multiple cancer indications. Benzinga had the opportunity to chat with Briggs Morrison, M.D., Syndax's CEO and director. The interview took place at a time when the...